Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Sectors
  2. /Health

Health

19 VCs and 1 funds investing in Health

VCs investing in Health

Sebastian Wossagk

Managing Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Sebastian Wossagk is listed by Acton Capital as Managing Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Jörg Wernet

Director Finance

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Jörg Wernet is listed by Acton Capital as Director Finance. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Benedikt Sudbrock

General Counsel

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Benedikt Sudbrock is listed by Acton Capital as General Counsel. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Frank Seehaus

Managing Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Frank Seehaus is listed by Acton Capital as Managing Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Jan-Gisbert Schultze

Managing Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Jan-Gisbert Schultze is listed by Acton Capital as Managing Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Laura Schuhbauer-Josipovich

Principal

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Laura Schuhbauer-Josipovich is listed by Acton Capital as Principal. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Isabel Rafeiner

Associate

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Isabel Rafeiner is listed by Acton Capital as Associate. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Fritz Oidtmann

Managing Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Fritz Oidtmann is listed by Acton Capital as Managing Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Julius Lühr

Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Julius Lühr is listed by Acton Capital as Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Dominique Krötz

Team Assistant

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Dominique Krötz is listed by Acton Capital as Team Assistant. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Paul-Bernhard Kallen

Managing Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Paul-Bernhard Kallen is listed by Acton Capital as Managing Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Joseph Hefele

Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Joseph Hefele is listed by Acton Capital as Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Christina Catania

Investor Relations

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Christina Catania is listed by Acton Capital as Investor Relations. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Leon Buchholz

Senior Finance Manager

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Leon Buchholz is listed by Acton Capital as Senior Finance Manager. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Christoph Braun

Managing Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Christoph Braun is listed by Acton Capital as Managing Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Hannes Blum

Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Hannes Blum is listed by Acton Capital as Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Dominik Alvermann

Managing Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Dominik Alvermann is listed by Acton Capital as Managing Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Sophie Ahrens-Gruber

Venture Partner

80%

Acton Capital

Check: Acton publishes a typical initial investment of €5M-€10M.

Sophie Ahrens-Gruber is listed by Acton Capital as Venture Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back European and Canadian companies at Series A and beyond with durable, capital-aware growth strategies rather than hype-driven scaling.

Series AGrowth Stage

Marius Dissler

Analyst

80%

Polytechnique Ventures

Check: Polytechnique Ventures publishes €50K-€250K pre-seed, €250K-€1M seed and approximately €1M-€3M Series A tickets.

Marius Dissler is listed by Polytechnique Ventures as Analyst. No narrower personal thesis is asserted beyond the firm's published strategy: Invest in high-technology startups from the École Polytechnique ecosystem, typically alongside other professional early-stage investors.

Pre-SeedSeedSeries A

Funds focused on Health

Acton Capital

Munich, Germany

18 people0 investments